Developer docs
API playgroundTry for free, no card

Search company profiles

Institut Marques

Full company profile

uuid000tggv

Namestring
Institut Marques
Legal namestring
Institut Marquès
Company typeenum
Private
Founded yearint
1920
Descriptiontext

Institut Marquès is a Barcelona-headquartered assisted reproduction clinic group operating four physical centers — two in Spain (Barcelona, Sabadell) and two in Italy (Rome, Milan) — with an additional Irish site acquired in 2016 (Clane Fertility Clinic) and a claimed operating history stretching back to approximately 1920. It is currently structured as an affiliate of the Czech-incorporated reproductive-medicine platform FutureLife a.s., and serves self-pay individual patients across heterosexual couples, lesbian couples (via the ROPA method), single mothers, transgender individuals (through fertility preservation), and oncology patients requiring pre-treatment gamete cryopreservation.

The clinical offering spans standard IVF, Mini IVF, IVF with egg or sperm donation, Tandem IVF, embryo donation, artificial insemination, and a full fertility-preservation suite (egg, sperm, and embryo freezing via vitrification). Supporting techniques include PGT preimplantation genetic testing, ICSI and IMSI sperm injection, blastocyst culture, micromanipulation, the Fertile microfluidic sperm-selection chip, an Embryobile patient-facing app for real-time embryo monitoring, and a proprietary Music in Incubators system. Institut Marquès markets publicly reported success-rate metrics (91.5% with donor eggs, 95.1% high-quality embryo rate) and offers an outcome-linked financial product — IM Premium Pregnancy Insurance, refunding 70% of fees if pregnancy is not achieved within three cycles. Sub-brands include Rainbow Fertility Barcelona (LGBTQ+-focused) and the 2018-launched CSR initiative The Embryo Forest.

The business model is a professional-services clinic operation monetized per treatment cycle, with revenue diversified across core IVF procedures, complementary laboratory techniques, fertility preservation, diagnostics, and the refund-guarantee program. Go-to-market is multilingual (6-language website) and oriented toward both domestic patients and cross-border fertility tourism, with direct appointment booking through the website and phone across all four centers.

Short descriptiontext

Institut Marquès is a Barcelona-headquartered fertility clinic group operating four centers in Spain and Italy (plus an Irish acquisition), delivering IVF, donor-IVF, ROPA, fertility preservation, and complementary embryology techniques to self-pay domestic and European fertility-tourism patients under FutureLife a.s. ownership.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
fertility treatments, assisted reproduction, IVF services, fertility preservation, reproductive medicine
Industry4 codes
PRIMARYHLAFAJAD
Fertility, Reproductive Endocrinology & IVF Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
SECONDARYHLAKAJAC
Reproductive Endocrinology & Infertility (IVF/Fertility)
SECONDARYTHAKAIAF
Fertility/IVF & Reproductive Tourism Agencies
Travel & Hospitality/Travel Agencies, Tour Operators & OTAs/Medical Tourism Agencies & Facilitators
SECONDARYHLAKAOAD
Male Reproductive & Sexual Medicine (Andrology)
NAICS code1 code
  • Family Planning Centers621410
SIC code1 code
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Fertility Clinic Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1Fertility Treatments
TypeProfessional Services
Description

Core revenue from assisted reproduction treatments including IVF, Mini IVF, IVF with egg/sperm donation, ROPA method, Tandem IVF, and embryo donation. Also includes artificial insemination services.

institutomarques.com
2Fertility Preservation
TypeProfessional Services
Description

Revenue from egg freezing, sperm freezing, and embryo freezing services for fertility preservation purposes.

institutomarques.com
3Complementary Techniques
TypeProfessional Services
Description

Additional revenue from advanced techniques including PGT (Preimplantation Genetic Testing), ICSI, IMSI, Time-Lapse incubation, blastocyst culture, and micromanipulation.

institutomarques.com
4Fertility Studies and Diagnostics
TypeProfessional Services
Description

Revenue from diagnostic services including female and male fertility studies, genetic counseling, and genetic compatibility testing.

institutomarques.com
5IM Premium Pregnancy Insurance
TypeManaged Services
Description

Insurance/refund program where patients receive 70% refund if successful pregnancy is not achieved after three cycles, providing financial guarantee and risk mitigation.

institutomarques.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1IM Premium Pregnancy Insurance
ModelOutcome Based/ PerformanceBilling cadenceMulti-year contract
Notes

70% refund of treatment costs if pregnancy not achieved after three cycles. Insurance covers everything necessary for treatment.

institutomarques.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 4 records shown
1The Embryo Forest (El Bosque de los Embriones / La Foresta degli Embrioni)
Description

Corporate Social Responsibility initiative launched in 2018 that plants a tree for every child born through their treatments

institutomarques.com
+3 more records
Core offering1 text field

Institut Marquès is an integrated fertility clinic operating four centers in Spain (Barcelona, Sabadell) and Italy (Rome, Milan), delivering assisted reproduction treatments including IVF, Mini IVF, IVF with egg/sperm donation, ROPA method, Tandem IVF, embryo donation, and artificial insemination. The clinics complement treatments with fertility preservation (egg, sperm, and embryo freezing), complementary techniques such as ICSI, IMSI, PGT genetic testing, time-lapse incubation, and proprietary systems including the Music in Incubators system and Embryobile app.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 91.5% success rate for IVF with donor eggs
+2 more records
Product overview1 text field

Institut Marquès is a multi-location assisted reproduction clinic offering a comprehensive portfolio of fertility treatments and diagnostic services. The core offering includes IVF treatments (standard, Mini IVF, with egg/sperm donation, ROPA, and Tandem), artificial insemination, embryo donation, and fertility preservation (egg, sperm, and embryo freezing). These are supported by complementary techniques including Time Lapse Incubator monitoring, ICSI/IMSI sperm selection, PGT genetic testing, Blastocyst culture, and the proprietary Embryobile real-time monitoring system. The clinic also provides genetic testing services, fertility studies, and complementary services such as the Erotic Personal System for sample collection. Institut Marquès operates four centers (Barcelona, Sabadell, Rome, Milan) and offers financial programs including IM Premium Pregnancy Insurance with a 70% refund guarantee. The organization is part of the FutureLife Group.

Product and service16 records
1In Vitro Fertilization (IVF)
CategoryCore fertility treatment
Description

Standard IVF treatment where egg fertilization by sperm occurs outside the mother's body in a specialized laboratory setting, available to couples and individuals facing infertility.

2Mini IVF
CategoryCore fertility treatment
Description

Minimally stimulated IVF treatment using lower hormone doses for egg production, suitable for patients seeking gentler stimulation protocols.

3IVF with Egg Donation
CategoryCore fertility treatment
Description

IVF treatment using donated eggs from carefully screened donors combined with partner or donor sperm, for women with diminished ovarian reserve or poor egg quality.

4IVF with Sperm Donation
CategoryCore fertility treatment
Description

IVF treatment using donated sperm from carefully screened donors for fertilization, serving single women, lesbian couples, and heterosexual couples with male factor infertility.

5ROPA Method
CategoryCore fertility treatment
Description

Reception of Oocytes from Partner treatment for female couples where one partner provides the eggs and the other carries the pregnancy, enabling both partners to participate biologically.

6Tandem IVF
CategoryCore fertility treatment
Description

Combined IVF treatment using both the partner's and donor's eggs simultaneously to maximize success chances for patients with diminished ovarian reserve.

7Embryo Donation
CategoryCore fertility treatment
Description

Treatment using embryos donated by other couples who have completed their family, for patients requiring both egg and sperm donation.

8Artificial Insemination
CategoryCore fertility treatment
Description

Simple assisted reproduction technique depositing optimized sperm directly into the uterus during ovulation, used as a first-line fertility treatment.

9Egg Freezing
CategoryFertility preservation
Description

Vitrification-based preservation of eggs for future use, maintaining reproductive potential for women delaying childbearing or undergoing medical treatments.

10Sperm Freezing
CategoryFertility preservation
Description

Cryopreservation of sperm samples for later use in fertility treatments, including for patients undergoing medical procedures that may affect fertility.

11Embryo Freezing
CategoryFertility preservation
Description

Vitrification-based preservation of embryos for future fertility treatments, allowing patients to preserve surplus embryos from IVF cycles.

12PGT (Preimplantation Genetic Testing)
CategoryComplementary technique
Description

Genetic testing of embryos before transfer to screen for chromosomal abnormalities and hereditary diseases, available as part of IVF treatment plans.

13Female Fertility Study
CategoryDiagnostic service
Description

Comprehensive assessment of female reproductive health and ovarian reserve, used as a diagnostic service for women evaluating their fertility status.

14Male Fertility Study
CategoryDiagnostic service
Description

Spermiogram analysis evaluating sperm quantity, motility, and morphology for men evaluating their fertility status or presenting with male factor infertility.

15Genetic Compatibility Testing
CategoryGenetic testing service
Description

Blood test for couples to determine if both partners are carriers of the same recessive genetic disease, supporting informed family planning.

16Genetic Counseling
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeOthers
Description

Rainbow Fertility Barcelona is a project of Institut Marquès specifically designed to serve the LGBTQ+ community more effectively, offering specialized fertility treatments including ROPA method for lesbian couples and fertility preservation for transgender individuals.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

UK fertility chain specializing in mild and natural-cycle IVF (Mini IVF analogues), serving patients seeking lower-stimulation protocols; directly comparable to Institut Marquès' Mini IVF and personalized-protocol positioning.

TypeDirect peer
Description

Barcelona-based fertility clinic group with strong focus on international patients and a comparable portfolio of IVF, egg donation, and cross-border reproductive services; now integrated with IVI-RMA but historically a direct competitor in Spain.

TypeEmerging player
Description

Czech fertility clinic with strong cross-border patient focus, offering IVF, egg/sperm donation, and PGT at competitive price points; competes with Institut Marquès in the value-oriented international patient segment.

TypeDirect peer
Description

Historic UK IVF clinic (founded by the original IVF pioneers) operating multiple UK sites with full IVF, ICSI, and donor conception services; comparable in brand heritage, breadth of techniques, and cross-cycle success guarantees.

TypeDirect peer
Description

Czech-Polish fertility clinic group also part of the FutureLife parent network; comparable in procedure mix (IVF, donor programs, PGT) and in serving international fertility-tourism patients in Central Europe.

TypeDirect peer
Description

UK-based multi-clinic fertility chain offering IVF, donor conception, and complementary genetic services, serving a similar patient profile with a focus on personalized treatment and strong published success rates.

TypeDirect peer
Description

Spain-origin IVF clinic chain operating one of Europe's largest fertility networks, with similar IVF, egg donation, and fertility preservation offerings as Institut Marquès, and overlapping Spanish patient base in Barcelona.

TypeRegional player
Description

Greek fertility clinic specializing in cross-border patients from Italy, UK, and Germany; overlaps with Institut Marquès on donor-IVF and surrogacy-adjacent fertility tourism flows from Mediterranean markets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile7 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Institut Marques

Fertility Clinic Servicesinstitutomarques.com

Institut Marquès is a Barcelona-headquartered fertility clinic group operating four centers in Spain and Italy (plus an Irish acquisition), delivering IVF, donor-IVF, ROPA, fertility preservation, and complementary embryology techniques to self-pay domestic and European fertility-tourism patients under FutureLife a.s. ownership.

What Institut Marques does

Institut Marquès is a Barcelona-headquartered assisted reproduction clinic group operating four physical centers — two in Spain (Barcelona, Sabadell) and two in Italy (Rome, Milan) — with an additional Irish site acquired in 2016 (Clane Fertility Clinic) and a claimed operating history stretching back to approximately 1920. It is currently structured as an affiliate of the Czech-incorporated reproductive-medicine platform FutureLife a.s., and serves self-pay individual patients across heterosexual couples, lesbian couples (via the ROPA method), single mothers, transgender individuals (through fertility preservation), and oncology patients requiring pre-treatment gamete cryopreservation.

The clinical offering spans standard IVF, Mini IVF, IVF with egg or sperm donation, Tandem IVF, embryo donation, artificial insemination, and a full fertility-preservation suite (egg, sperm, and embryo freezing via vitrification). Supporting techniques include PGT preimplantation genetic testing, ICSI and IMSI sperm injection, blastocyst culture, micromanipulation, the Fertile microfluidic sperm-selection chip, an Embryobile patient-facing app for real-time embryo monitoring, and a proprietary Music in Incubators system. Institut Marquès markets publicly reported success-rate metrics (91.5% with donor eggs, 95.1% high-quality embryo rate) and offers an outcome-linked financial product — IM Premium Pregnancy Insurance, refunding 70% of fees if pregnancy is not achieved within three cycles. Sub-brands include Rainbow Fertility Barcelona (LGBTQ+-focused) and the 2018-launched CSR initiative The Embryo Forest.

The business model is a professional-services clinic operation monetized per treatment cycle, with revenue diversified across core IVF procedures, complementary laboratory techniques, fertility preservation, diagnostics, and the refund-guarantee program. Go-to-market is multilingual (6-language website) and oriented toward both domestic patients and cross-border fertility tourism, with direct appointment booking through the website and phone across all four centers.

Institut Marques firmographics

Firmographics
Name
Institut Marques
Legal name
Institut Marquès
Website
https://institutomarques.com
Company type
Private
Founded year
1920
Operating status
Operating
Headcount range
101–250 employees
Short description
Institut Marquès is a Barcelona-headquartered fertility clinic group operating four centers in Spain and Italy (plus an Irish acquisition), delivering IVF, donor-IVF, ROPA, fertility preservation, and complementary embryology techniques to self-pay domestic and European fertility-tourism patients under FutureLife a.s. ownership.
Ownership category
akta.pro rank

Institut Marques industry classification

Industry
Product category
Fertility Clinic Services
NAICS
Family Planning Centers (621410)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro industry
PRIMARYHLAFAJAD
Fertility, Reproductive Endocrinology & IVF Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
SECONDARYHLAKAJAC
Reproductive Endocrinology & Infertility (IVF/Fertility)
SECONDARYTHAKAIAF
Fertility/IVF & Reproductive Tourism Agencies
Travel & Hospitality/Travel Agencies, Tour Operators & OTAs/Medical Tourism Agencies & Facilitators
SECONDARYHLAKAOAD
Male Reproductive & Sexual Medicine (Andrology)

Keywords

  • Fertility treatments
  • Assisted reproduction
  • IVF services
  • Fertility preservation
  • Reproductive medicine

Where Institut Marques is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices4 records

Markets served

Institut Marques business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Fertility Treatments: Core revenue from assisted reproduction treatments including IVF, Mini IVF, IVF with egg/sperm donation, ROPA method, Tandem IVF, and embryo donation. Also includes artificial insemination services.
  2. Fertility Preservation: Revenue from egg freezing, sperm freezing, and embryo freezing services for fertility preservation purposes.
  3. Complementary Techniques: Additional revenue from advanced techniques including PGT (Preimplantation Genetic Testing), ICSI, IMSI, Time-Lapse incubation, blastocyst culture, and micromanipulation.
  4. Fertility Studies and Diagnostics: Revenue from diagnostic services including female and male fertility studies, genetic counseling, and genetic compatibility testing.
  5. IM Premium Pregnancy Insurance: Insurance/refund program where patients receive 70% refund if successful pregnancy is not achieved after three cycles, providing financial guarantee and risk mitigation.

Pricing tiers

ModelBillingPrice
Outcome Based/ PerformanceMulti-year contractIM Premium Pregnancy Insurance

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Institut Marques product offering

Product offering

Core offering

Institut Marquès is an integrated fertility clinic operating four centers in Spain (Barcelona, Sabadell) and Italy (Rome, Milan), delivering assisted reproduction treatments including IVF, Mini IVF, IVF with egg/sperm donation, ROPA method, Tandem IVF, embryo donation, and artificial insemination. The clinics complement treatments with fertility preservation (egg, sperm, and embryo freezing), complementary techniques such as ICSI, IMSI, PGT genetic testing, time-lapse incubation, and proprietary systems including the Music in Incubators system and Embryobile app.

Product overview

Institut Marquès is a multi-location assisted reproduction clinic offering a comprehensive portfolio of fertility treatments and diagnostic services. The core offering includes IVF treatments (standard, Mini IVF, with egg/sperm donation, ROPA, and Tandem), artificial insemination, embryo donation, and fertility preservation (egg, sperm, and embryo freezing). These are supported by complementary techniques including Time Lapse Incubator monitoring, ICSI/IMSI sperm selection, PGT genetic testing, Blastocyst culture, and the proprietary Embryobile real-time monitoring system. The clinic also provides genetic testing services, fertility studies, and complementary services such as the Erotic Personal System for sample collection. Institut Marquès operates four centers (Barcelona, Sabadell, Rome, Milan) and offers financial programs including IM Premium Pregnancy Insurance with a 70% refund guarantee. The organization is part of the FutureLife Group.

Differentiator

Problem solved

Functional benefit

Brands

  • The Embryo Forest (El Bosque de los Embriones / La Foresta degli Embrioni): Corporate Social Responsibility initiative launched in 2018 that plants a tree for every child born through their treatments
  • Rainbow Fertility Barcelona
  • IM Premium Pregnancy Insurance
  • Erotic Personal System (EPS)

Products and services

  • In Vitro Fertilization (IVF) Standard IVF treatment where egg fertilization by sperm occurs outside the mother's body in a specialized laboratory setting, available to couples and individuals facing infertility.
  • Mini IVF Minimally stimulated IVF treatment using lower hormone doses for egg production, suitable for patients seeking gentler stimulation protocols.
  • IVF with Egg Donation IVF treatment using donated eggs from carefully screened donors combined with partner or donor sperm, for women with diminished ovarian reserve or poor egg quality.
  • IVF with Sperm Donation IVF treatment using donated sperm from carefully screened donors for fertilization, serving single women, lesbian couples, and heterosexual couples with male factor infertility.
  • ROPA Method Reception of Oocytes from Partner treatment for female couples where one partner provides the eggs and the other carries the pregnancy, enabling both partners to participate biologically.
  • Tandem IVF Combined IVF treatment using both the partner's and donor's eggs simultaneously to maximize success chances for patients with diminished ovarian reserve.
  • Embryo Donation Treatment using embryos donated by other couples who have completed their family, for patients requiring both egg and sperm donation.
  • Artificial Insemination Simple assisted reproduction technique depositing optimized sperm directly into the uterus during ovulation, used as a first-line fertility treatment.
  • Egg Freezing Vitrification-based preservation of eggs for future use, maintaining reproductive potential for women delaying childbearing or undergoing medical treatments.
  • Sperm Freezing Cryopreservation of sperm samples for later use in fertility treatments, including for patients undergoing medical procedures that may affect fertility.
  • Embryo Freezing Vitrification-based preservation of embryos for future fertility treatments, allowing patients to preserve surplus embryos from IVF cycles.
  • PGT (Preimplantation Genetic Testing) Genetic testing of embryos before transfer to screen for chromosomal abnormalities and hereditary diseases, available as part of IVF treatment plans.
  • Female Fertility Study Comprehensive assessment of female reproductive health and ovarian reserve, used as a diagnostic service for women evaluating their fertility status.
  • Male Fertility Study Spermiogram analysis evaluating sperm quantity, motility, and morphology for men evaluating their fertility status or presenting with male factor infertility.
  • Genetic Compatibility Testing Blood test for couples to determine if both partners are carriers of the same recessive genetic disease, supporting informed family planning.
  • Genetic Counseling

Quantifiable outcome

  • 91.5% success rate for IVF with donor eggs
  • +2 more outcomes

Companies that use Institut Marques

Customer profile

Named customers2 records

Segments7 records

Ideal customer profiles7 records

Institut Marques technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Institut Marques partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Rainbow Fertility BarcelonaminorOthersRainbow Fertility Barcelona is a project of Institut Marquès specifically designed to serve the LGBTQ+ community more effectively, offering specialized fertility treatments including ROPA method for lesbian couples and fertility preservation for transgender individuals.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Institut Marques competitors and assessment

Company assessment

Direct peers

  • CREATE Fertility: UK fertility chain specializing in mild and natural-cycle IVF (Mini IVF analogues), serving patients seeking lower-stimulation protocols; directly comparable to Institut Marquès' Mini IVF and personalized-protocol positioning.
  • Eugin: Barcelona-based fertility clinic group with strong focus on international patients and a comparable portfolio of IVF, egg donation, and cross-border reproductive services; now integrated with IVI-RMA but historically a direct competitor in Spain.
  • Bourn Hall Clinic: Historic UK IVF clinic (founded by the original IVF pioneers) operating multiple UK sites with full IVF, ICSI, and donor conception services; comparable in brand heritage, breadth of techniques, and cross-cycle success guarantees.
  • Gyncentrum: Czech-Polish fertility clinic group also part of the FutureLife parent network; comparable in procedure mix (IVF, donor programs, PGT) and in serving international fertility-tourism patients in Central Europe.
  • CARE Fertility: UK-based multi-clinic fertility chain offering IVF, donor conception, and complementary genetic services, serving a similar patient profile with a focus on personalized treatment and strong published success rates.
  • IVI-RMA (IVI Global): Spain-origin IVF clinic chain operating one of Europe's largest fertility networks, with similar IVF, egg donation, and fertility preservation offerings as Institut Marquès, and overlapping Spanish patient base in Barcelona.

Emerging players

  • Reprofit: Czech fertility clinic with strong cross-border patient focus, offering IVF, egg/sperm donation, and PGT at competitive price points; competes with Institut Marquès in the value-oriented international patient segment.

Regional players

  • Newlife IVF Greece: Greek fertility clinic specializing in cross-border patients from Italy, UK, and Germany; overlaps with Institut Marquès on donor-IVF and surrogacy-adjacent fertility tourism flows from Mediterranean markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Institut Marques social profiles

Digital presence

Institut Marques financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Institut Marques leadership team

Management profile

Number of profiles

Profiles9 records

Institut Marques subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Institut Marques funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Institut Marques M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institut Marques

What does Institut Marques do?

Institut Marquès is an integrated fertility clinic operating four centers in Spain (Barcelona, Sabadell) and Italy (Rome, Milan), delivering assisted reproduction treatments including IVF, Mini IVF, IVF with egg/sperm donation, ROPA method, Tandem IVF, embryo donation, and artificial insemination. The clinics complement treatments with fertility preservation (egg, sperm, and embryo freezing), complementary techniques such as ICSI, IMSI, PGT genetic testing, time-lapse incubation, and proprietary systems including the Music in Incubators system and Embryobile app.

Is Institut Marques a public or private company?

Institut Marques is a private company. It is classified as corporate owned and is currently operating.

When was Institut Marques founded?

Institut Marques was founded in 1920. It employs 101 to 250 people.

Where is Institut Marques based?

Institut Marques is headquartered in London, United Kingdom, in the Europe region.

How does Institut Marques make money?

Five revenue lines are on record. Fertility Treatments are the primary driver. The others are fertility Preservation, complementary Techniques, fertility Studies and Diagnostics and IM Premium Pregnancy Insurance.

Who are Institut Marques's main competitors?

Direct peers on record are CREATE Fertility, Eugin, Bourn Hall Clinic, Gyncentrum, CARE Fertility and IVI-RMA (IVI Global). Reprofit is listed as an emerging player. Newlife IVF Greece is listed as a regional player.

Does Institut Marques have an API?

No public API is recorded for Institut Marques.

What industry is Institut Marques in?

Institut Marques's product category is Fertility Clinic Services. Its primary akta.pro industry code is HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers, with a secondary code of HLAKAJAC, Reproductive Endocrinology & Infertility (IVF/Fertility). Its NAICS code is 621410 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireInstitut Marquès Invited by the Imperial College of London to Present Latest Developments in Front of 700 ResearchersInstitut Marquès, a Spanish assisted reproduction center based in Barcelona, was invited by Imperial College London to present its latest research findings to an audience of over 700 researchers. The center showcased several innovations including the Babypod intravaginal speaker, which research shows improves IVF fertilisation rates by 5%, along with its Embryomobile app for real-time embryo monitoring and a patented telemedicine technique for remote sperm cryopreservation. Founded over 95 years ago, Institut Marquès also presented findings linking semen quality to erotic visual stimulation through virtual reality in their study of assisted reproduction technologies.PR NewswireSharon Corr et Álex Ubago ont célébré le prix Ig Nobel de l'Institut Marquès en chantant à des embryonsInstitut Marquès, an international fertility center in Barcelona, hosted a concert for embryos featuring Irish singer Sharon Corr and Spanish artist Álex Ubago, performing for hundreds of embryos in incubators at the center's laboratories. The event celebrated the Ig Nobel Prize in Medicine awarded by Harvard University in September for the center's research demonstrating that musical vibrations during IVF fertilization increase success rates by 5% and promote embryonic development. Institut Marquès plans to continue organizing similar concerts and aims to recreate natural uterine conditions for embryos grown in laboratory settings.PR NewswireSharon Corr and Álex Ubago Celebrated Institut Marquès' Ig Nobel Prize by Singing to the EmbryosInstitut Marquès, a fertility center in Barcelona, hosted a live concert featuring Sharon Corr and Álex Ubago performing for embryos in laboratory incubators, celebrating the clinic's Ig Nobel Prize awarded by Harvard University for research on music's benefits to embryonic development. The clinic's studies, which have been presented at the Karolinska Institute and Aarhus University, demonstrated that musical vibrations during IVF fertilization increase success rates by 5%. Institut Marquès plans to continue offering live concerts at its laboratories and has implemented music systems in all embryo incubators to recreate natural uterine conditions.PR NewswireSharon Corr e Álex Ubago hanno celebrato il premio Ig Nobel dell'Institut Marquès cantando agli embrioniInstitut Marquès, a Barcelona-based fertility clinic, hosted a live concert featuring Sharon Corr and Álex Ubago performing for embryos growing in incubators across its laboratories in Barcelona, Rome, and Clane, Ireland. The clinic, which received an Ig Nobel Prize in Medicine from Harvard University for its research on music's benefits in embryonic development, reported that musical vibrations during IVF fertilization increased success rates by 5%. Institut Marquès plans to continue offering live concerts in its laboratories as part of its ongoing studies on recreating natural uterine conditions for embryos.PR NewswireUne étude de l’Institut Marquès démontre que la contamination atmosphérique de l’air du laboratoire de FIV impacte de manière negative le développement des embryonsL'Institut Marquès a présenté lors des Journées Nationales de la Société de Médecine de Reproduction à Montpellier une étude démontrant que la contamination atmosphérique affecte négativement le développement des embryons lors des cycles de fécondation in vitro.PR NewswireInstitut Marquès Research on Foetal Hearing and the Effect of Music on Early Life Presented at the Ig NobelInstitut Marquès, a gynecology and assisted reproduction center based in Barcelona, Spain, presented their research on foetal hearing at the European Ig Nobel Tour at universities in Sweden and Denmark and at Aarhus University in Copenhagen. Their research, which earned them the Ig Nobel Prize for Medicine in Obstetrics at Harvard University, demonstrates that foetuses can hear from the 16th week onwards only when sound reaches them directly from the vagina, debunking the common practice of talking through the belly. The centre has also applied musical vibrations in their IVF incubators, and their vaginal loudspeaker product Babypod is now being used by thousands of women to communicate with their babies during pregnancy.PR NewswireEl mito de hablarle al bebé a través de la barriga de la madre es historiaInstitut Marquès, a gynecology and assisted reproduction center based in Barcelona, presented findings at Ig Nobel Tour events in Sweden and Denmark demonstrating that fetuses can hear from week 16 of pregnancy, but only when sound reaches them directly via the vagina using their Babypod device — contradicting the widespread belief that speaking to a pregnant woman's belly is effective. The research, for which Director Dr. Marisa López-Teijón received the Ig Nobel Prize in Medicine, also found that applying musical vibrations to IVF incubators improves fertilization outcomes. Thousands of women are now using Babypod to communicate with their unborn babies.PR NewswireInstitut Marquès stellt seine Studien zu Musik und dem Beginn des Lebens am Massachusetts Institute of Technology vorInstitut Marquès, an international fertility center based in Barcelona, received the Ig Nobel Prize for Medicine at Harvard University and MIT in September 2017 — the first award in obstetrics in the prize's 27-year history. The center presented research showing that fetuses can begin hearing at 16 weeks of pregnancy (11 cm/4 inches) when sound is transmitted vaginally, using their FDA-approved Babypod device connected to mobile phones. The study, published in the journal Ultrasound, demonstrated that fetuses respond to vaginal music with speech-like movements, suggesting neurological stimulation and early language learning can begin in utero.PR NewswireL'Institut Marquès présente ses études sur la musique et le début de la vie au Massachusetts Institute of TechnologyInstitut Marquès, a renowned assisted reproduction center based in Barcelona, presented its fetal hearing research at MIT and received the Ig Nobel Prize in Medicine at Harvard, the first-ever awarded in obstetrics in the award's 27-year history. The study, published in the journal Ultrasound, discovered that fetuses begin hearing at 16 weeks (when measuring 11 cm) via vaginal sound transmission, challenging the previously accepted medical threshold of 26 weeks. Institut Marquès developed the FDA-approved Babypod vaginal speaker to enable fetal music stimulation and neurological communication with unborn babies.PR NewswireInstitut Marquès presenta sus estudios sobre música e inicio de la vida en el Instituto Tecnológico de MassachusettsInstitut Marquès, a fertility and assisted reproduction center, presented its research on the influence of music on embryonic and fetal development at the Massachusetts Institute of Technology (MIT) on September 18, 2017. The study, published in the journal Ultrasound, found that fetuses begin hearing at 16 weeks of gestation (11 cm) when sound is delivered vaginally, and led to the creation of the Babypod, an FDA-approved vaginal speaker device. Dr. Marisa López-Teijón, director of Institut Marquès, received the Ig Nobel Prize in Medicine—the first ever awarded in the field of Obstetrics in the award's 27-year history—at a ceremony jointly held by Harvard University and MIT.